[1]刘玉振.孟鲁司特治疗支气管哮喘的临床研究[J].医学信息,2018,31(10):140-142.[doi:10.3969/j.issn.1006-1959.2018.10.047]
　LIU Yu-zhen.Clinical Study of Montelukast in the Treatment of Bronchial Asthma[J].Journal of Medical Information,2018,31(10):140-142.[doi:10.3969/j.issn.1006-1959.2018.10.047]
点击复制

孟鲁司特治疗支气管哮喘的临床研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年10期
页码:
140-142
栏目:
药物与临床
出版日期:
2018-05-15

文章信息/Info

Title:
Clinical Study of Montelukast in the Treatment of Bronchial Asthma
文章编号:
1006-1959（2018）10-0140-03
作者:
刘玉振
天津市宁河区医院药剂科，天津 301500
Author(s):
LIU Yu-zhen
Department of Pharmacy,Tianjin Ninghe District Hospital,Tianjin 301500,China
关键词:
支气管哮喘; 孟鲁司特; 临床症状评分
Keywords:
Key words：Bronchial asthma; Montelukast; Clinical symptom score
分类号:
R562.2+5
DOI:
10.3969/j.issn.1006-1959.2018.10.047
文献标志码:
A
摘要:
目的 分析孟鲁司特对支气管哮喘患者的治疗效果及影响，为临床提供参考。方法 选取2016年1月~2017年1月我院收治的90例支气管哮喘患者，以随机数表法分成观察组与对照组，各45例。对照组予以常规治疗，观察组在常规治疗基础上加用孟鲁司特钠治疗，对比观察两组患者治疗总有效率、临床症状评分及不良反应情况。结果 观察组患者临床治疗总有效率94.33%，高于对照组77.78%，差异有统计学意义（P＜0.05）；观察组临床症状评分（0.71±0.23）分，低于对照组（1.67±0.26）分，差异有统计学意义（P＜0.05）。观察组不良反应率4.40%与对照组6.60%对比，差异无统计学意义（P＞0.05）。结论 孟鲁司特对支气管哮喘患者的治疗效果显著，与常规治疗相比，其不仅可有效提高临床疗效，而且可有效减少不良反应发生率，值得临床推广。
Abstract:
Abstract：Objective To analyze the treatment effect and influence of montelukast on bronchial asthma patients and provide reference for clinical practice.Methods A total of 90 patients with bronchial asthma admitted to our hospital from January 2016 to January 2017 were randomly divided into observation group and control group,45 cases each.The control group was given routine treatment. The observation group was treated with montelukast sodium on the basis of conventional treatment.The total treatment efficacy,clinical symptom scores,and adverse reactions were compared between the two groups.Results The total effective rate of clinical treatment in observation group was 94.33%,which was higher than 77.78% in control group,the difference was statistically significant(P<0.05);the clinical symptom score of the observation group(0.71±0.23)was lower than that of the control group(1.67±0.26),and the difference was statistically significant(P<0.05).The adverse reaction rate in the observation group was 4.40% compared with 6.60% in the control group,with no statistically significant difference(P>0.05).Conclusion Montelukast has a significant therapeutic effect on bronchial asthma patients.Compared with conventional treatment,montelukast can not only effectively improve clinical efficacy,but also can effectively reduce the incidence of adverse reactions and is worthy of clinical promotion.

参考文献/References:

[1]彭秋凤,高静珍.重度哮喘应用舒利迭联合孟鲁司特治疗的效果分析[J].中国生化药物杂志,2017,8(37):429-430.
[2]刘芳英,申燕华,钱叶长.白三烯调节剂在支气管哮喘药物治疗中的研究进展[J].临床荟萃,2013,28(8):947-950.
[3]叶军辉,余贤广.孟鲁司特联合布地奈德对哮喘患者Th1/Th2平衡及肺功能的影响[J].中国药业,2013,22(03):3-4.
[4]王华启.孟鲁司特对哮喘急性发作期患者外周血炎症因子的影响[J].广东医学，2013,34（01）：124-125.
[5]陈琳,唐聪,吴蕾.孟鲁司特治疗支气管哮喘的疗效及对患者免疫状态的影响[J].中国生化药物杂志,2017,37(2):249-251.
[6]李宏涛.孟鲁司特治疗支气管哮喘对患者免疫反应的影响探讨[J].基层医学论坛,2016,20(35):4995-4996.
[7]吴家礼.孟鲁司特对支气管哮喘患者的治疗效果及影响研究[J].中国继续医学教育,2017,9(2):165-167.

相似文献/References:

[1]焦龙龙,郭悦鹏.初诊哮喘患者的呼出气一氧化氮与大小气道功能的 相关性及临床价值分析[J].医学信息,2018,31(06):70.[doi:10.3969/j.issn.1006-1959.2018.06.022]
　JIAO Long-long,GUO Yue-peng.Correlation and Clinical Value Analysis of Exhaled Nitric Oxide and Airway Function in Patients with Newly Diagnosed Asthma[J].Journal of Medical Information,2018,31(10):70.[doi:10.3969/j.issn.1006-1959.2018.06.022]
[2]井庆彦.治未病三伏贴对支气管哮喘缓解期患者 冬病夏治的疗效观察[J].医学信息,2018,31(17):143.[doi:10.3969/j.issn.1006-1959.2018.17.045]
　JING Qing-yan.Therapeutic Effect of Preventive Treatment of Disease of Sanfu Paster on Summer Treatment of Winter Disease in Patients with Bronchial Asthma[J].Journal of Medical Information,2018,31(10):143.[doi:10.3969/j.issn.1006-1959.2018.17.045]
[3]赵 静,陈华琴,张 宁,等.血清骨膜蛋白和脂联素联检诊断儿童支气管哮喘价值研究[J].医学信息,2018,31(21):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
　ZHAO Jing,CHEN Hua-qin,ZHANG Ning,et al.Diagnostic Value of Serum Periosteal Protein and Adiponectin in Children with Bronchial Asthma[J].Journal of Medical Information,2018,31(10):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
[4]王晓燕,梁 萍,董艳婷.非特异性免疫疗法在支气管哮喘治疗中的应用进展[J].医学信息,2019,32(05):57.[doi:10.3969/j.issn.1006-1959.2019.05.018]
　WANG Xiao-yan,LIANG Ping,DONG Yan-ting.Progress in the Application of Non-specific Immunotherapy in the Treatment of Bronchial Asthma[J].Journal of Medical Information,2019,32(10):57.[doi:10.3969/j.issn.1006-1959.2019.05.018]
[5]孟琳非,黄伟健,酆孟洁,等.基于聚类分析对慢性肺部疾病表型的研究进展[J].医学信息,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
　MENG Lin-fei,HUANG Wei-jian,FENG Meng-jie,et al.Advances in Research on Phenotypes of Chronic Lung Diseases Based on Cluster Analysis[J].Journal of Medical Information,2019,32(10):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
[6]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
　WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Journal of Medical Information,2019,32(10):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[7]易晓明,彭小娜.氧气驱动雾化吸入对支气管哮喘患者肺功能及血氧饱和度的影响[J].医学信息,2019,32(23):110.[doi:10.3969/j.issn.1006-1959.2019.23.030]
　YI Xiao-ming,PENG Xiao-na.Effect of Oxygen-Driven Aerosol Inhalation on Lung Function and Oxygen Saturation in Patients with Bronchial Asthma[J].Journal of Medical Information,2019,32(10):110.[doi:10.3969/j.issn.1006-1959.2019.23.030]
[8]张 斌,刘宿慧,余长寿.孟鲁司特联合噻托溴铵对COPD患者血清细胞因子、血液流变学及肺功能的影响[J].医学信息,2020,33(02):144.[doi:10.3969/j.issn.1006-1959.2020.02.043]
　ZHANG Bin,LIU Su-hui,YU Chang-shou.Effect of Montelukast Combined with Tiotropium Bromide on Serum Cytokines,Hemorheology and Lung Function in Patients with COPD[J].Journal of Medical Information,2020,33(10):144.[doi:10.3969/j.issn.1006-1959.2020.02.043]
[9]曾穗茹,王蓉梅.孟鲁司特联合布地奈德雾化吸入用于肺炎支原体感染后慢性咳嗽患儿的效果观察[J].医学信息,2018,31(19):137.[doi:10.3969/j.issn.1006-1959.2018.19.041]
　ZENG Sui-ru,WANG Rong-mei.Efficacy of Montelukast Combined with Budesonide Aerosol Inhalation in Children with Chronic Cough after Mycoplasma Pneumoniae Infection[J].Journal of Medical Information,2018,31(10):137.[doi:10.3969/j.issn.1006-1959.2018.19.041]
[10]王启龙,张 蔚.支气管哮喘急性发作并肺部感染患者血清炎性因子、免疫球蛋白水平与预后的相关性分析[J].医学信息,2021,34(22):81.[doi:10.3969/j.issn.1006-1959.2021.22.024]
　WANG Qi-long,ZHANG Wei.Correlation Analysis of Serum Inflammatory Factors, Immunoglobulin Levels and Prognosis in Patients with Acute Exacerbation of Bronchial Asthma Complicated with Pulmonary Infection[J].Journal of Medical Information,2021,34(10):81.[doi:10.3969/j.issn.1006-1959.2021.22.024]
[11]杨一民,黄小玲,李 溦,等.LTA4H基因多态性对汉族儿童支气管哮喘患者使用孟鲁司特钠疗效及肺功能的影响[J].医学信息,2022,35(20):49.[doi:10.3969/j.issn.1006-1959.2022.20.011]
　YANG Yi-min,HUANG Xiao-ling,LI Wei,et al.Effect of LTA4H Gene Polymorphism on the Efficacy and Lung Function of Montelukast Sodium in Chinese Han Children with Bronchial Asthma[J].Journal of Medical Information,2022,35(10):49.[doi:10.3969/j.issn.1006-1959.2022.20.011]

更新日期/Last Update: 2018-05-15